Keep up to date with all the latest ARMI news and events. We know your inbox is overflowing, so we promise to only share important news and events with you – we hate SPAM too.
New Grant to Support ARMI Research in Understanding Blindness in Newborns
A grant funded by the Angior Family Foundation has been awarded to ARMI to study Leber Congenital Amaurosis (LCA), a group of inherited retinal diseases that are the most common cause of blindness in newborn children. The project will be led by Senior Research Fellow Dr Joachim Berger from the Currie Group. “I would like […]
npj Regenerative Medicine Passes Significant Milestones
npj Regenerative Medicine, an online journal created by ARMI in partnership with Nature Springer, has passed two exciting new milestones. Impact factor (IF) data recently released by Clarivate Analytics has revealed that npj Regenerative Medicine has a debut IF of 7.021 and is ranked in the first quartile for citations in both of the journal’s […]
ARMI Scientists Harness Computing Power to Unlock Biological Networks
A new algorithm developed by ARMI researchers is set to become the gold standard in network analysis. Called “Integrated Value of Influence (IVI),” the algorithm will help systems biology scientists better understand development and disease. The work, led by PhD student Adrian (Abbas) Salavaty from the Currie Group, was recently published in Patterns– a Cell […]
ARMI Scientists Working to Improve Regenerative Medicine
New research from ARMI scientists outlines a novel method of enhancing regenerative activity, with clinical implications on improving the effectiveness of growth factors-based therapies. Recently published in the journal Science Advances, the work was spearheaded by Dr Ziad Julier and Associate Professor Mikaël Martino, in collaboration with researchers from Switzerland and Japan. The findings explored […]
ARMI From Home: Q&A with Pete Currie – Part II
The COVID-19 pandemic has necessitated an unprecedented and coordinated response from every corner of the community, and this includes ARMI. To do our bit to help ‘flatten the curve,’ ARMI implemented its working from home plan in late March. For scientists who are often in the lab doing experiments, trying to troubleshoot by talking to […]
ARMI From Home: Q&A with Pete Currie – Part I
The COVID-19 pandemic has necessitated an unprecedented and coordinated response from every corner of the community, and this includes ARMI. To do our bit to help ‘flatten the curve,’ ARMI implemented its working from home plan in late March. For scientists who are often in the lab doing experiments, trying to troubleshoot by talking to […]
New Research Unveils the Secret Life of White Blood Cells
New research led by ARMI scientists has unveiled how white blood cells move and carry out their functions at the cellular and subcellular level – at a resolution at which we have not seen before. PhD student Harriet Manley spearheaded the work with ARMI Group leader Professor Graham Lieschke which was recently published in the […]
Our Bold Vision: ARMI’s Strategic Plan 2020-2025
ARMI is delighted to unveil our 2020-2025 Strategic Plan; designed to realise ARMI’s vision of improved quality of life by unlocking the body’s innate regenerative potential. The five-year plan is a roadmap to support the Institute’s mission to discover new regenerative therapies through conducting cutting edge research and forming collaborative networks with the best scientists […]
Luke Belfield: Bringing Diverse Experience To ARMI’s DEC
It’s been a busy time for the Development Engagement Committee (DEC) as we welcome yet another member to its ranks. Today, ARMI is excited to welcome Luke Belfield! First and foremost, Luke is an experienced infrastructure professional. His ambitious nature has led to over 15 years of experience across numerous fields, with qualifications in mechanical […]
Dr Chris Sotiropoulos: The Ambition To Change The World Through Innovation
ARMI is pleased to welcome Dr Chris Sotiropoulos to our array of subject matter experts on the Development Engagement Committee (DEC)! Chris has over 25 years of global expertise in the commercialisation of innovative healthcare and IT products, bringing ambition and experience to the DEC. Chris is a ‘Jack-Of-All-Trades’ with not only a PhD in […]